FDA Reviews New Data on Anemia Drugs:
Over-prescribing for profit
International Herald Tribune
Expert Summary
The FDA is again reviewing new data on anemia drugs, but previous warnings haven't stopped physicians from potentially over-prescribing dangerous anemia drugs and getting sizable rebates.
Irina Ostrovsky-Day
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(1 review)
01/18/2008
Think the big drug companies aren't corrupt or have hidden agendas-- think again.
Add your rating:
click to select